Cell Reports
(Jan 2015)
Notch2 Is Required for Inflammatory Cytokine-Driven Goblet Cell Metaplasia in the Lung
Henry Danahay,
Angelica D. Pessotti,
Julie Coote,
Brooke E. Montgomery,
Donghui Xia,
Aaron Wilson,
Haidi Yang,
Zhao Wang,
Luke Bevan,
Chris Thomas,
Stephanie Petit,
Anne London,
Peter LeMotte,
Arno Doelemeyer,
Germán L. Vélez-Reyes,
Paula Bernasconi,
Christy J. Fryer,
Matt Edwards,
Paola Capodieci,
Amy Chen,
Marc Hild,
Aron B. Jaffe
Affiliations
Henry Danahay
Respiratory Disease Area, Novartis Institutes for BioMedical Research, Horsham RH12 5AB, UK
Angelica D. Pessotti
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Julie Coote
Respiratory Disease Area, Novartis Institutes for BioMedical Research, Horsham RH12 5AB, UK
Brooke E. Montgomery
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Donghui Xia
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Aaron Wilson
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Haidi Yang
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Zhao Wang
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Luke Bevan
Respiratory Disease Area, Novartis Institutes for BioMedical Research, Horsham RH12 5AB, UK
Chris Thomas
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Stephanie Petit
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Anne London
Novartis Biologics Center, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Peter LeMotte
Novartis Biologics Center, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Arno Doelemeyer
Discovery and Investigative Pathology, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland
Germán L. Vélez-Reyes
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Paula Bernasconi
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Christy J. Fryer
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Matt Edwards
Respiratory Disease Area, Novartis Institutes for BioMedical Research, Horsham RH12 5AB, UK
Paola Capodieci
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Amy Chen
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Marc Hild
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
Aron B. Jaffe
Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA
DOI
https://doi.org/10.1016/j.celrep.2014.12.017
Journal volume & issue
Vol. 10,
no. 2
pp.
239
– 252
Abstract
Read online
The balance and distribution of epithelial cell types is required to maintain tissue homeostasis. A hallmark of airway diseases is epithelial remodeling, leading to increased goblet cell numbers and an overproduction of mucus. In the conducting airway, basal cells act as progenitors for both secretory and ciliated cells. To identify mechanisms regulating basal cell fate, we developed a screenable 3D culture system of airway epithelial morphogenesis. We performed a high-throughput screen using a collection of secreted proteins and identified inflammatory cytokines that specifically biased basal cell differentiation toward a goblet cell fate, culminating in enhanced mucus production. We also demonstrate a specific requirement for Notch2 in cytokine-induced goblet cell metaplasia in vitro and in vivo. We conclude that inhibition of Notch2 prevents goblet cell metaplasia induced by a broad range of stimuli and propose Notch2 neutralization as a therapeutic strategy for preventing goblet cell metaplasia in airway diseases.
WeChat QR code
Close